www.antimicrobe.org

[Start Page] [Microbes] [Antimicrobial Agents] [HIV Clinical Manual] [Feedback] [Logout]

Streptococcus pneumoniae

 

 

Read the Chapter

Sliding Table of Contents on the left of the screen

 

Tables and Figures

Table 1:  Definitions of Pneumococcal Resistance to ß-Lactam Antibiotics

Table 2. Pneumococcal (N=1531) Resistance (%) to Antibiotics in 33 Centers in the USA  (1999-2000). 

Table 3: Representative Peak Serum Concentrations of ß-Lactam Antibiotics in Reference to in vitro Resistance in Adults. 

Table 3-a: Time Above MIC for Three Oral and Four Parenteral β-lactam Antibiotics Tested against Penicillin-Intermediate and Penicillin-Resistant Strains of Streptococcus pneumoniae

Table 4. Recommended Therapy for Penicillin-Susceptible and -Resistant Pneumococcal Infections.

Table 5. Antimicrobial Therapy Recommendations for Children and Adults with Meningitis Caused by Streptococcus pneumoniae on the Basis of Susceptibility Tests Results

Table 6. Recommended Daily Dosages of Agents Commonly Used for Treatment of Non-Meningeal Pneumococcal Infections. See Table 4 For Selection Of Antibacterial Agent.

Table 7. Serum And Middle Ear Fluid Concentrations of  Antimicrobial Agents that Have Been Used for Therapy of Childhood Otitis Media and Comparative In Vitro Activity According to Pneumococcal Susceptibility to Penicillin. 

Table 8: Antimicrobial Therapy Recommendations for Children with Acute Otitis Media (AOM) caused by Streptococcus pneumoniae on the Basis of Susceptibility Tests Results

Table 9: Published Reports on Mono vs. Combo in Treatment of Pneumonia (listed in the order of time published)

 

Vignettes

Review Article: Bogaert D, De Groot R, Hermans PW. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis. 2004 Mar;4(3):144-54.

Review Article: Holzman D. Community-Acquired Pneumonia Drug Resistance Patterns Prove Puzzling. ASM News. 2004 Nov;70(11):571-4.

Review Article: van de Beek D, de Gans J, McIntyre P, Prasad K. Steroids in adults with acute bacterial meningitis: a systematic review. Lancet Infect Dis. 2004 Mar;4(3):139-43.

Review Article: Chiou CC, Yu VL.  Severe pneumococcal pneumonia: new strategies for management. Curr Opin Crit Care Med 2006;12:470-476.

Review Article:  Efflux Pumps as a Mechanism of Antimicrobial Resistance. 2008

Review Article:  Hsu et al. Effect of Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis. N Engl J Med. 2009 Jan 15;360(3):244-56.

Review Article:  Tebruegge M, et al. Epidemiology, Etiology, Pathogenesis, and Diagnosis of Recurrent Bacterial Meningitis. Clin Microbiol Rev 2008;21:519-537.

Patient Handout:  Pneumococcal Polysaccharide Vaccine

Guidelines:  ACIP: Updated Recommendations for Prevention of Invasive Pneumococcal Disease Among Adults Using the 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23). MMWR Sept 2010.

Guchev IA, Yu VL, et al.  Management of Nonsevere Pneumonia in Military Trainees with the Urinary Antigen Test for Streptococcus pneumoniae: An innovative Approach to Targeted Therapy.  Clin Infect Dis 2005;40:1608-16.

Gram stain, 2008.

Tsai CJ, et al, Changing Epidemiology of Pneumococcal Meningitis After the Introduction of Pneumococcal Conjugate Vaccine in the United States. Clin Infect Dis. 2008 Jun 1;46(11):1664-72.

Jackson LA and Janoff EN. Pneumococcal Vaccination of Elderly Adults: New Paradigms for Protection.  Clin Infect Dis. 2008 Nov 15;47(10):1328-38.

Johnstone J, et al. Impact of the pneumococcal vaccine on long-term morbidity and mortality of adults at high risk for pneumonia. Clin Infect Dis. 2010 Jul 1;51:15-22.

 

Authors

  Christine C Chiou, M.D.,   David Greenberg M.D., Keith P. Klugman, M.D., Ph.D.,

  Charles Feldman, M.D.

First Edition (1998): Ian R. Friedland and George H. McCracken

 

www.antimicrobe.org

[Start Page] [Microbes] [Antimicrobial Agents] [HIV Clinical Manual] [Feedback] [Logout]